Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 Sep;3(5):511–516. doi: 10.1128/cdli.3.5.511-516.1996

Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

D C Powers 1, E D Kilbourne 1, B E Johansson 1
PMCID: PMC170398  PMID: 8877127

Abstract

Little information is available on the potential role of antibody to influenza virus neuraminidase (NA) in vaccine-induced immunity. In the present study, serologic responses to the N1Texas/91 and N2Beijing/92 NA components of trivalent inactivated influenza virus vaccine were measured by NA inhibition (NI) and enzyme-linked immunosorbent assay (ELISA), and the results for adults aged 18 to 45 (young) or > or = 65 (elderly) years were compared. The two age groups had comparable rates (32 to 50%) of NI response. In contrast, ELISA immunoglobulin G (IgG) antibody responses to N1 and N2 NAs occurred in 70 to 71 and 67 to 83%, respectively, of young subjects but in only 3 to 18 and 18 to 35%, respectively, of elderly subjects. prevaccination mean ELISA IgG and IgA NA antibody titers were generally lower for the young adults than they were for the elderly, whereas the corresponding NI titers were comparable. In young adults, plaque size-reducing NA antibody increases were positively associated with ELISA but not with NI antibody increases. There were no apparent age-related differences in the immunoglobulin isotype distribution of the anti-NA response, with IgG being the dominant class and IgG1 the dominant subclass of serum antibody. Anti-hemagglutinin antibody responses to H1Texas/91 and H3Beijing/92 were greater in magnitude and frequency than the corresponding NA-specific responses to N1Texas/91 and N2Beijing/92 when measured by hemagglutination inhibition and NI, respectively, but not when measured by ELISA. The discordance between NI and ELISA for measurement of NA-specific vaccine responses may reflect the relative insensitivity of NI in discriminating differences when initial antibody titers are low.

Full Text

The Full Text of this article is available as a PDF (189.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clements M. L., Murphy B. R. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol. 1986 Jan;23(1):66–72. doi: 10.1128/jcm.23.1.66-72.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Coles F. B., Balzano G. J., Morse D. L. An outbreak of influenza A (H3N2) in a well immunized nursing home population. J Am Geriatr Soc. 1992 Jun;40(6):589–592. doi: 10.1111/j.1532-5415.1992.tb02108.x. [DOI] [PubMed] [Google Scholar]
  3. Couch R. B., Kasel J. A., Gerin J. L., Schulman J. L., Kilbourne E. D. Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J Infect Dis. 1974 Apr;129(4):411–420. doi: 10.1093/infdis/129.4.411. [DOI] [PubMed] [Google Scholar]
  4. Fedson D. S., Fulk R. V., Huber M. A., Reisberg M. A., Kasel J. A. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine. J Immunol. 1971 Sep;107(3):730–737. [PubMed] [Google Scholar]
  5. Feery B. J., Evered M. G., Morrison E. I. Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. J Infect Dis. 1979 Feb;139(2):237–241. doi: 10.1093/infdis/139.2.237. [DOI] [PubMed] [Google Scholar]
  6. Gross P. A., Ennis F. A., Gaerlan P. F., Denson L. J., Denning C. R., Schiffman D. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J Infect Dis. 1977 Nov;136(5):623–632. doi: 10.1093/infdis/136.5.623. [DOI] [PubMed] [Google Scholar]
  7. Hammarström L., Smith C. I. IgG subclass changes in response to vaccination. Monogr Allergy. 1986;19:241–252. [PubMed] [Google Scholar]
  8. Hocart M. J., Mackenzie J. S., Stewart G. A. Serum IgG subclass responses of humans to inactivated and live influenza A vaccines compared to natural infections with influenza A. J Med Virol. 1990 Feb;30(2):92–96. doi: 10.1002/jmv.1890300203. [DOI] [PubMed] [Google Scholar]
  9. Jahiel R. I., Kilbourne E. D. Reduction in plaque size and reduction in plaque number as differing indices of influenza virus-antibody reactions. J Bacteriol. 1966 Nov;92(5):1521–1534. doi: 10.1128/jb.92.5.1521-1534.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Johansson B. E., Bucher D. J., Kilbourne E. D. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J Virol. 1989 Mar;63(3):1239–1246. doi: 10.1128/jvi.63.3.1239-1246.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Johansson B. E., Kilbourne E. D. Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition. J Virol. 1993 Oct;67(10):5721–5723. doi: 10.1128/jvi.67.10.5721-5723.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johansson B. E., Moran T. M., Kilbourne E. D. Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6869–6873. doi: 10.1073/pnas.84.19.6869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kasel J. A., Couch R. B., Six H. R., Knight V. Antigenicity of licensed whole virion and subvirion influenza vaccines in "high risk" persons. Proc Soc Exp Biol Med. 1976 Apr;151(4):742–747. doi: 10.3181/00379727-151-39298. [DOI] [PubMed] [Google Scholar]
  14. Kendal A. P., Bozeman F. M., Ennis F. A. Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. Infect Immun. 1980 Sep;29(3):966–971. doi: 10.1128/iai.29.3.966-971.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kendal A. P., Minuse E., Maassab H. F., Hennessy A. V., Davenport F. M. Influenza neuraminidase antibody patterns of man. Am J Epidemiol. 1973 Aug;98(2):96–103. doi: 10.1093/oxfordjournals.aje.a121543. [DOI] [PubMed] [Google Scholar]
  16. Kendal A. P., Noble G. R., Dowdle W. R. Neuraminidase content of influenza vaccines and neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. J Infect Dis. 1977 Dec;136 (Suppl):S415–S424. doi: 10.1093/infdis/136.supplement_3.s415. [DOI] [PubMed] [Google Scholar]
  17. Kida H., Webster R. G., Yanagawa R. Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus. Arch Virol. 1983;76(2):91–99. doi: 10.1007/BF01311693. [DOI] [PubMed] [Google Scholar]
  18. Kilbourne E. D., Cerini C. P., Khan M. W., Mitchell J. W., Jr, Ogra P. L. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees. J Immunol. 1987 May 1;138(9):3010–3013. [PubMed] [Google Scholar]
  19. Kilbourne E. D. Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans. J Infect Dis. 1976 Oct;134(4):384–394. doi: 10.1093/infdis/134.4.384. [DOI] [PubMed] [Google Scholar]
  20. Kilbourne E. D., Couch R. B., Kasel J. A., Keitel W. A., Cate T. R., Quarles J. H., Grajower B., Pokorny B. A., Johansson B. E. Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans. Vaccine. 1995 Dec;13(18):1799–1803. doi: 10.1016/0264-410x(95)00127-m. [DOI] [PubMed] [Google Scholar]
  21. Kilbourne E. D., Laver W. G., Schulman J. L., Webster R. G. Antiviral activity of antiserum specific for an influenza virus neuraminidase. J Virol. 1968 Apr;2(4):281–288. doi: 10.1128/jvi.2.4.281-288.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Monto A. S., Kendal A. P. Effect of neuraminidase antibody on Hong Kong influenza. Lancet. 1973 Mar 24;1(7804):623–625. doi: 10.1016/s0140-6736(73)92196-x. [DOI] [PubMed] [Google Scholar]
  23. Morens D. M., Rash V. M. Lessons from a nursing home outbreak of influenza A. Infect Control Hosp Epidemiol. 1995 May;16(5):275–280. doi: 10.1086/647107. [DOI] [PubMed] [Google Scholar]
  24. Murphy B. R., Kasel J. A., Chanock R. M. Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med. 1972 Jun 22;286(25):1329–1332. doi: 10.1056/NEJM197206222862502. [DOI] [PubMed] [Google Scholar]
  25. Odelin M. F., Pozzetto B., Aymard M., Defayolle M., Jolly-Million J. Role of influenza vaccination in the elderly during an epidemic of A/H1N1 virus in 1988-1989: clinical and serological data. Gerontology. 1993;39(2):109–116. doi: 10.1159/000213520. [DOI] [PubMed] [Google Scholar]
  26. Ogra P. L., Chow T., Beutner K. R., Rubi E., Strussenberg J., DeMello S., Rizzone C. Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans. J Infect Dis. 1977 Apr;135(4):499–506. doi: 10.1093/infdis/135.4.499. [DOI] [PubMed] [Google Scholar]
  27. Potter C. W., Oxford J. S. Determinants of immunity to influenza infection in man. Br Med Bull. 1979 Jan;35(1):69–75. doi: 10.1093/oxfordjournals.bmb.a071545. [DOI] [PubMed] [Google Scholar]
  28. Powers D. C. Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine. J Med Virol. 1994 May;43(1):57–61. doi: 10.1002/jmv.1890430111. [DOI] [PubMed] [Google Scholar]
  29. Powers D. C., Hanscome P. J., Pietrobon P. J. In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant. Vaccine. 1995 Oct;13(14):1330–1335. doi: 10.1016/0264-410x(95)00002-i. [DOI] [PubMed] [Google Scholar]
  30. Powers D. C., Murphy B. R., Fries L. F., Adler W. H., Clements M. L. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies. J Am Geriatr Soc. 1992 Feb;40(2):163–167. doi: 10.1111/j.1532-5415.1992.tb01938.x. [DOI] [PubMed] [Google Scholar]
  31. Powers D. C., Smith G. E., Anderson E. L., Kennedy D. J., Hackett C. S., Wilkinson B. E., Volvovitz F., Belshe R. B., Treanor J. J. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. J Infect Dis. 1995 Jun;171(6):1595–1599. doi: 10.1093/infdis/171.6.1595. [DOI] [PubMed] [Google Scholar]
  32. Remarque E. J., van Beek W. C., Ligthart G. J., Borst R. J., Nagelkerken L., Palache A. M., Sprenger M. J., Masurel N. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines. Vaccine. 1993;11(6):649–654. doi: 10.1016/0264-410x(93)90311-k. [DOI] [PubMed] [Google Scholar]
  33. Spiegelberg H. L. Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol. 1974;19(0):259–294. doi: 10.1016/s0065-2776(08)60254-0. [DOI] [PubMed] [Google Scholar]
  34. Treanor J. J., Betts R. F., Smith G. E., Anderson E. L., Hackett C. S., Wilkinson B. E., Belshe R. B., Powers D. C. Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults. J Infect Dis. 1996 Jun;173(6):1467–1470. doi: 10.1093/infdis/173.6.1467. [DOI] [PubMed] [Google Scholar]
  35. Virelizier J. L. Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J Immunol. 1975 Aug;115(2):434–439. [PubMed] [Google Scholar]
  36. Wagner D. K., Clements M. L., Reimer C. B., Snyder M., Nelson D. L., Murphy B. R. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum. J Clin Microbiol. 1987 Mar;25(3):559–562. doi: 10.1128/jcm.25.3.559-562.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yoden S., Kida H., Kuwabara M., Yanagawa R., Webster R. G. Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody. Virus Res. 1986 May;4(3):251–261. doi: 10.1016/0168-1702(86)90004-3. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES